Zhaoke Ophthalmology Limited (SEHK: 6622)
Health Care · Pharmaceuticals · CN
HK$2.27
-8.65% today · -29.1% 1Y
Zhaoke Ophthalmology Limited (SEHK: 6622) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $158.23M and employs 276 people.
Over the last twelve months the share price has lost 29.1%, trading between 2.26 and 3.85.
Tweenvest scores Zhaoke Ophthalmology Limited across four factors: quality 46/100, value 68/100. Its strongest factor is value.
6622 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $158.23M
- Revenue (TTM)
- $5.15M
- P/E
- —
- EPS
- -0.39
- Dividend yield
- —
- Beta (5Y)
- 1.10
- 52-week high
- HK$3.85
- 52-week low
- HK$2.26
- Avg volume (3M)
- —
- Shares outstanding
- 547.03M
- Employees
- 276
- Next earnings
- —
About Zhaoke Ophthalmology Limited
Zhaoke Ophthalmology Limited is an ophthalmic pharmaceutical company dedicated to researching, developing, and commercializing therapeutic solutions addressing significant unmet medical requirements in the People's Republic of China. The company is advancing a range of medications designed for various ocular conditions, impacting both the anterior and posterior segments of the eye, such as dry eye disease, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. It was previously known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was established in 2017 and operates from its headquarters in Guangzhou, People's Republic of China.
- ISIN
- KYG989M51017
- Founded
- 2017
- Listed since
- Apr 29, 2021
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| JETEMA, Co., Ltd.KOSDAQ: A216080 | $163.64M | ₩5,900.00 | -1.67% |
| MediWound Ltd.NasdaqGM: MDWD | $161.89M | $12.53 | -0.08% |
| Accent Microcell LimitedNSEI: ACCENTMIC | $161.05M | Rs649.75 | -3.01% |
| Hyundai Pharmaceutical Co., Ltd.KOSE: A004310 | $159.76M | ₩7,760.00 | -6.95% |
| TerrAscend Corp.TSX: TSND | $157.10M | CA$0.73 | -3.33% |
| AGP LimitedKASE: AGP | $156.49M | PKRs155.48 | +2.42% |
| Cenra Inc.TWSE: 3716 | $155.60M | NT$34.15 | +0.74% |
| Societe de Promotion Pharmaceutique du Maghreb S.A.CBSE: PRO | $155.42M | MAD— | — |
Figures last refreshed Oct 11, 2026.